Piperidine derivatives having effects on serotonin related systems
申请人:Eli Lilly and Company
公开号:US06436964B1
公开(公告)日:2002-08-20
The present invention provides the compounds of the following formula:
Wherein the variables are as defined in the specification and a method for inhibiting the reuptake of seretonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of the compound of above formula.
Piperidine derivatives as serotonine reuptake inhibitors
申请人:Eli Lilly and Company
公开号:US06664274B1
公开(公告)日:2003-12-16
The present invention provides compounds of formula I
and a method of inhibiting the reuptake of serotonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of a compound of formula I.
Azepine derivatives having effects on serotonin related systems
申请人:Eli Lilly and Company
公开号:US06465453B1
公开(公告)日:2002-10-15
The present invention provides compounds of formula I and a method of inhibiting the reuptake of serotonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of a compound of formula I.
Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
申请人:Eli Lilly and Company
公开号:US06353008B1
公开(公告)日:2002-03-05
The present invention provides the compounds of the following formula (I):
and a method for inhibiting the reuptake of seretonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of formula (I).